OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Chest Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Indoor Air Pollution and Respiratory Health	91
Silicosis: An Update and Guide for Clinicians	61
Allergic Bronchopulmonary Aspergillosis	56
Diagnosis of Primary Ciliary Dyskinesia	40
Pneumothorax	37
Working in Smoke:	35
The Respiratory Risks of Ambient/Outdoor Air Pollution	29
Sex Differences in Pulmonary Hypertension	29
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease	29
Coal Workers’ Pneumoconiosis and Other Mining-Related Lung Disease	28
Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension	26
Pleural Tuberculosis	24
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation	20
Sex Differences in Obstructive Sleep Apnea	19
Gender Differences in Critical Illness and Critical Care Research	18
Pleural Fluid Analysis	17
Pulmonary Hypertension in Left Heart Disease	17
Adaptation and Maladaptation of the Right Ventricle in Pulmonary Vascular Diseases	16
Patient-Centered and Family-Centered Care in the Intensive Care Unit	16
Congenital Heart Disease-Associated Pulmonary Hypertension	16
The Changing Nature of Wildfires	16
Nontuberculous Mycobacteria	16
Respiratory Health Effects of Exposure to Cleaning Products	15
Screening for Occupational Lung Cancer	15
Microbiology and the Microbiome in Bronchiectasis	15

Nontuberculous Mycobacterial Infections in Cystic Fibrosis	15
Parapneumonic Effusion and Empyema	15
Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome	14
Chylothorax and Pseudochylothorax	14
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections	13
Bronchiectasis in Childhood	13
Sleep Deficiency	13
Update on Clinical Outcomes of Highly Effective Modulator Therapy	13
Medical Thoracoscopy	13
Occupational Contributions to Interstitial Lung Disease	12
The Need for Social and Environmental Determinants of Health Research to Understand and Intervene on Racial/Ethnic Disparities in Obstructive Sleep Apnea	12
Diagnosis and Evaluation of Bronchiectasis	12
Health Disparities in Environmental and Occupational Lung Disease	11
Update on Innate and Adaptive Immunity in Cystic Fibrosis	11
Coronavirus Disease-2019 in the Immunocompromised Host	11
Differences Between Men and Women with Chronic Obstructive Pulmonary Disease	10
Future Directions in Bronchiectasis Research	10
Management of Connective Tissue Disease-Associated Interstitial Lung Disease	10
Interstitial Lung Disease in 2020	10
Sleep Deficiency and Cardiometabolic Disease	10
Women and Lung Cancer	10
Radiology of Bronchiectasis	9
Sleep Deficiency and Opioid Use Disorder	9
Lessons Learned from Health Disparities in Coronavirus Disease-2019 in the United States	9
Preoperative Assessment and Perioperative Management of the Patient with Pulmonary Vascular Disease	9
Supporting Professionals in Critical Care Medicine	9
Pulmonary Hypertension in Pregnancy	9
Occupational Bronchiolitis	9
Sleep Deficiency, Sleep Apnea, and Chronic Lung Disease	9
The Role of Exercise Testing in Pulmonary Vascular Disease	9
Challenges Faced by Women with Cystic Fibrosis	9
SARS-CoV-2 Infection and COVID-19 in Children	9
Interstitial Lung Diseases and the Impact of Gender	8
Management of Idiopathic Pulmonary Fibrosis	8
Integrative Omics to Characterize and Classify Pulmonary Vascular Disease	8
Management of Pneumothorax	8
The Impact of Social Determinants of Health on Gender Disparities Within Respiratory Medicine	8
Sleep Deficiency in Young Children	8
Malignant Pleural Effusions	8
Update on Climate Change	8
Clinical Relevance and Management of “Pre–Interstitial Lung Disease”	8
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era	8
Indwelling Pleural Catheters	7
Lung Transplant Procedure of Choice	7
Work Around the Clock	7
Genetics of Cystic Fibrosis	7
Pulmonary Considerations for Pregnant Women	7
Survivorship After Critical Illness and Post-Intensive Care Syndrome	7
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice	7
Management of Mental Health in Cystic Fibrosis	7

Obstetric Disorders and Critical Illness	7
Diagnosis and Management of Fibrotic Interstitial Lung Diseases	7
Climate Change, Air Quality, and Pulmonary Health Disparities	7
Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis	7
COVID-19 in Patients with Chronic Lung Disease	6
Group 3 Pulmonary Hypertension	6
Disparities in Sleep-Disordered Breathing: Upstream Risk Factors, Mechanisms, and Implications	6
Joining Forces	6
Sleep Deficiency in the Elderly	6
COVID-19 and the Transformation of Intensive Care Unit Telemedicine	6
Asthma and Chronic Obstructive Pulmonary Disease	6
Advances in Ventilator Management for Patients with Acute Respiratory Distress Syndrome	6
Family Planning and Reproductive Health in Cystic Fibrosis	6
Chest Imaging in the Diagnosis of Occupational Lung Diseases	6
Pulmonary Arterial Hypertension Secondary to Drugs and Toxins	6
Bronchiectasis from 2012 to 2022	6
Sex Differences and the Role of Sex Hormones in Pulmonary Hypertension	6